Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Dan O who wrote (8753)	2/16/1999 9:35:00 PM
From: Bluegreen	Respond to of 17367

How long was trial supposed to last? If we get to middle of March and then it is said by a newsletter April, are you again going to say two weeks and what is the beef? I begin to see move to Bermuda, keeping mortality requirement from owners of the company, another discount to market price financing, etc. as maybe some things to contemplate very seriously now that sometime in March is put in a Biotech newsletter. Also McCammant doesn't even have Xoma on his radar screen as buys for new money, WHY IS THAT? He even has three tiers of buys for new money and Xoma is not on ANY OF THEM. Yes, I am very shocked and dismayed. Only my opinions and thoughts.